International Conference Features UCSF Breast Cancer Experts

Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 6 to 10, 2022. Combining clinical, translational and

More than 30 Researchers Among Most Influential

Thirty-six UC San Francisco researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate. HDFCCC Members (past and present) Alan Ashworth Oncology Jeffrey Bluestone Immunology Atul Butte

UCSF Mission Bay Receives ‘A’ Grade for Hospital Safety

UCSF Medical Center at Mission Bay has been nationally recognized with an “A” Hospital Safety Grade from The Leapfrog Group for its rigorous safety measures that protect hospital patients from harm and errors. The “A” grade, the highest rating, includes care provided at UCSF Betty Irene Moore Women

Myocarditis in Cancer Patients Is Driven by Specific Immune Cells

In a new study, researchers from UC San Francisco and Vanderbilt University Medical Center have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs. The researchers also identified the cells in heart

Marijuana and E-cigs Can Harm the Heart Like Traditional Cigarettes

E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UC San Francisco. The study is published November 15, 2022 in the journal Heart Rhythm. “We found that cigarettes, e-cigarettes

UCSF Cancer Specialist Recognized with Luminary Award for Gastrointestinal Cancers

Alan P. Venook MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers. Venook is being recognized for his achievements in the clinical practice and research of gastrointestinal cancers. Venook is a

“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells

In recent years, genetically re-engineered immune cells – armed with molecular weaponry to recognize and destroy tumor cells – have changed the landscape of cancer treatment. Now, UC San Francisco researchers have developed a new method for comparing massive numbers of these CAR-T cells, each with